DETECTION phase II/III trial: Circulating tumor DNA-guided therapy for stage IIB/C melanoma after surgical resection
Authors
Lee, Rebecca JRothwell, Dominic G
Jackson, R.
Smith, N.
Wong, S. Q.
Kelso, N.
Burghel, G.
Hewitt, C.
Clarke, H.
Mitchell, J.
Jones, K.
Muinonen-Martin, A.
Turajlic, S.
Corrie, P. G.
Marais, Richard
Middleton, M. R.
Dawson, S. J.
Sandhu, S.
Dive, Caroline
Lorigan, Paul C
Affiliation
The Christie NHS Foundation Trust, Manchester,Issue Date
2022
Metadata
Show full item recordCitation
Lee R, Rothwell DG, Jackson R, Smith N, Wong SQ, Kelso N, et al. DETECTION phase II/III trial: Circulating tumor DNA-guided therapy for stage IIB/C melanoma after surgical resection. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680305159.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2022.40.16_suppl.TPS9603Type
Meetings and Proceedingsae974a485f413a2113503eed53cd6c53
10.1200/JCO.2022.40.16_suppl.TPS9603